| pubmed-article:7882465 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7882465 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:7882465 | lifeskim:mentions | umls-concept:C0225828 | lld:lifeskim |
| pubmed-article:7882465 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:7882465 | lifeskim:mentions | umls-concept:C0003289 | lld:lifeskim |
| pubmed-article:7882465 | lifeskim:mentions | umls-concept:C0003290 | lld:lifeskim |
| pubmed-article:7882465 | lifeskim:mentions | umls-concept:C0814470 | lld:lifeskim |
| pubmed-article:7882465 | lifeskim:mentions | umls-concept:C0599732 | lld:lifeskim |
| pubmed-article:7882465 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:7882465 | lifeskim:mentions | umls-concept:C0205191 | lld:lifeskim |
| pubmed-article:7882465 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:7882465 | pubmed:dateCreated | 1995-4-13 | lld:pubmed |
| pubmed-article:7882465 | pubmed:abstractText | The capability of chronic tricyclic antidepressant drug (TAD) treatment to elicit myocardial damage has been a subject of debate. Lack of an adequate noninvasive method to detect such damage has prevented an in-depth study. | lld:pubmed |
| pubmed-article:7882465 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7882465 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7882465 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:7882465 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7882465 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7882465 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7882465 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7882465 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7882465 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:7882465 | pubmed:issn | 0009-7322 | lld:pubmed |
| pubmed-article:7882465 | pubmed:author | pubmed-author:AlvarezEE | lld:pubmed |
| pubmed-article:7882465 | pubmed:author | pubmed-author:ObradorDD | lld:pubmed |
| pubmed-article:7882465 | pubmed:author | pubmed-author:BallesterMM | lld:pubmed |
| pubmed-article:7882465 | pubmed:author | pubmed-author:MartíVV | lld:pubmed |
| pubmed-article:7882465 | pubmed:author | pubmed-author:CarrióII | lld:pubmed |
| pubmed-article:7882465 | pubmed:author | pubmed-author:Pons-LladóGG | lld:pubmed |
| pubmed-article:7882465 | pubmed:author | pubmed-author:UdinaCC | lld:pubmed |
| pubmed-article:7882465 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7882465 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:7882465 | pubmed:volume | 91 | lld:pubmed |
| pubmed-article:7882465 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7882465 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7882465 | pubmed:pagination | 1619-23 | lld:pubmed |
| pubmed-article:7882465 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:7882465 | pubmed:meshHeading | pubmed-meshheading:7882465-... | lld:pubmed |
| pubmed-article:7882465 | pubmed:meshHeading | pubmed-meshheading:7882465-... | lld:pubmed |
| pubmed-article:7882465 | pubmed:meshHeading | pubmed-meshheading:7882465-... | lld:pubmed |
| pubmed-article:7882465 | pubmed:meshHeading | pubmed-meshheading:7882465-... | lld:pubmed |
| pubmed-article:7882465 | pubmed:meshHeading | pubmed-meshheading:7882465-... | lld:pubmed |
| pubmed-article:7882465 | pubmed:meshHeading | pubmed-meshheading:7882465-... | lld:pubmed |
| pubmed-article:7882465 | pubmed:meshHeading | pubmed-meshheading:7882465-... | lld:pubmed |
| pubmed-article:7882465 | pubmed:meshHeading | pubmed-meshheading:7882465-... | lld:pubmed |
| pubmed-article:7882465 | pubmed:meshHeading | pubmed-meshheading:7882465-... | lld:pubmed |
| pubmed-article:7882465 | pubmed:meshHeading | pubmed-meshheading:7882465-... | lld:pubmed |
| pubmed-article:7882465 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7882465 | pubmed:articleTitle | Evaluation of myocardial cell damage by In-111-monoclonal antimyosin antibodies in patients under chronic tricyclic antidepressant drug treatment. | lld:pubmed |
| pubmed-article:7882465 | pubmed:affiliation | Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. | lld:pubmed |
| pubmed-article:7882465 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7882465 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7882465 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| pubmed-article:7882465 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
